Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Japan”
- A Study of Elafibranor in Adult Japanese Participants With Primary Biliary Cholangitis (PBC)Active Not Recruiting
Sponsor: Ipsen
Primary Biliary Cholangitis
Japan
Sponsor: BeOne Medicines
Advanced Solid Tumors
United States, Australia, China, Japan, Malaysia +3 more
- Clinical Study of MK-4884 in Participants With Advanced or Metastatic Solid Tumors (MK-4884-001)Recruiting
Sponsor: Merck Sharp & Dohme LLC
Malignant Neoplasm
United States, Israel, Japan, Switzerland
- A Study of Continued Treatment With Regorafenib in Participants With Solid Tumors Who Have Participated in Other Bayer StudiesActive Not Recruiting
Sponsor: Bayer
Solid Malignant Tumors
France, Japan, South Korea, Spain, Taiwan
- Pemafibrate for Symptomatic ICAS RCTRecruiting
Sponsor: Tokyo Women's Medical University
Intracranial Atherosclerotic Disease (ICAD) · Hypertriglyceridaemia · Stroke (CVA) or TIA
Japan
- A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's DiseaseActive Not Recruiting
Sponsor: Janssen Research & Development, LLC
Crohn Disease
United States, Australia, Belgium, Bosnia and Herzegovina, Brazil +22 more
- A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's DiseaseActive Not Recruiting
Sponsor: Janssen Research & Development, LLC
Crohn's Disease
United States, Australia, Austria, Belarus, Belgium +38 more
Sponsor: Bayer
Metastatic Hormone-sensitive Prostate Cancer (mHSPC) · Low-volume Metastasis
Japan
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Systemic Sclerosis
United States, Belgium, Canada, France, Germany +5 more
- A Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical ProstatectomyActive Not Recruiting
Sponsor: Janssen Research & Development, LLC
Prostatic Neoplasms
United States, Argentina, Australia, Brazil, Canada +13 more
Sponsor: Takeda
Protein C Deficiency
Japan
- A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight With and Without Type 2 DiabetesActive Not Recruiting
Sponsor: Eli Lilly and Company
Obesity · Overweight · Type 2 Diabetes
United States, Argentina, China, Czechia, Germany +2 more
- A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKEActive Not Recruiting
Sponsor: Janssen Research & Development, LLC
Ischemic Stroke; Ischemic Attack, Transient
United States, Argentina, Australia, Austria, Belgium +42 more
- A Study of Amivantamab and Capmatinib Combination Therapy in Unresectable Metastatic Non-small Cell Lung CancerActive Not Recruiting
Sponsor: Janssen Research & Development, LLC
Carcinoma, Non-Small-Cell Lung
United States, Brazil, Canada, China, France +8 more
- Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689)Active Not Recruiting
Sponsor: Merck Sharp & Dohme LLC
Head and Neck Neoplasms
United States, Argentina, Australia, Austria, Belgium +19 more
- A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative ColitisRecruiting
Sponsor: Janssen Research & Development, LLC
Colitis, Ulcerative
United States, Australia, Brazil, Canada, China +6 more
- A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's DiseaseActive Not Recruiting
Sponsor: Janssen-Cilag Ltd.
Fistulizing Crohns Disease · Perianal Crohns Disease
United States, Australia, Belgium, Canada, Czechia +18 more
Sponsor: Janssen Research & Development, LLC
Colorectal Neoplasms
United States, Belgium, Brazil, Canada, China +17 more
- A Rollover Study for Continued Study Treatment and Ongoing Safety MonitoringEnrolling By Invitation
Sponsor: Janssen Research & Development, LLC
Leukemia, Myeloid, Acute · Leukemia, Lymphocytic, Chronic, B-Cell · Lymphoma, Non-Hodgkin · Myelodysplastic Syndromes
Australia, Belgium, France, Georgia, Greece +9 more
- Study for AZD4360 in Participants With Advanced Solid TumoursActive Not Recruiting
Sponsor: AstraZeneca
Gastric Cancer · Gastroesophageal Junction Cancer · Biliary Tract Cancer · Pancreatic Ductal Adenocarcinoma
United States, China, Germany, Japan, United Kingdom
- A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or AblationActive Not Recruiting
Sponsor: Bristol-Myers Squibb
Hepatocellular Carcinoma · Liver Cancer
United States, Argentina, Australia, Austria, Belgium +20 more
Sponsor: Janssen Research & Development, LLC
Crohns Disease · Colitis, Ulcerative · Arthritis, Psoriatic · Arthritis, Juvenile
United States, Argentina, Australia, Brazil, China +11 more
Sponsor: Janssen Research & Development, LLC
Crohn Disease
United States, Argentina, Australia, Belgium, Brazil +23 more
- A Long-term Extension Study of Ustekinumab in Pediatric ParticipantsActive Not Recruiting
Sponsor: Janssen Research & Development, LLC
Crohn Disease · Colitis, Ulcerative · Arthritis, Psoriatic
United States, Argentina, Belgium, France, Germany +8 more
Sponsor: AstraZeneca
Heart Failure
United States, Argentina, Australia, Brazil, Bulgaria +30 more